バイオファブリケーション市場、規模、シェア、動向、産業分析レポート：技術、材料タイプ、用途、エンドユーザー、地域別 - 市場予測、2025年～2034年

Polaris Market Researchの最新調査によると、バイオファブリケーション市場規模は2034年までに316億9,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

バイオファブリケーション市場は、製薬会社や研究機関が医薬品開発パイプラインを進める中で、世界的にパイプライン医薬品が増加していることが主な要因となって成長しています。さまざまな開発段階にある医薬品が増加する中、ヒトの生体反応をシミュレートできる高度で正確な試験方法に対する需要が拡大しています。3Dプリンターで組織モデルを作成するバイオファブリケーション技術は、このニーズに有望なソリューションを提供します。これらの技術は、ヒトの臓器や器官を忠実に再現した複雑な組織構造の開発を可能にし、新薬の有効性と安全性を評価するための、より信頼性の高いプラットフォームを提供します。医薬品試験の精度を向上させ、動物モデルへの依存を減らし、製薬業界が新しい治療法や治療法への投資を続ける中で、倫理的・規制的な懸念に対処することができます。バイオファブリケーション市場は、革新的な検査ソリューションに対するニーズの高まりから利益を得ています。このような需要の高まりは、医薬品開発プロセスを加速し、医薬品研究の全体的な有効性を高める上で、バイオファブリケーションが重要な役割を果たしていることを裏付けています。

民間部門と公的部門による研究開発（R&D）への投資の増加は、予測期間中のバイオファブリケーション市場の成長を後押しすると予想されます。財政支援の拡大は、改良型3Dバイオプリンティングシステムや新規バイオマテリアルなど、バイオファブリケーション技術の進歩を可能にしています。このような投資の流入は技術革新を促進し、新しいアプリケーションの開発を加速し、バイオファブリケーション技術の能力を向上させる。資金が増加し続けることで、研究機関や企業は組織工学や再生医療に対するより洗練されたアプローチを探求することができ、市場の成長をさらに促進することができます。投資の増加は、先端技術の開発を支援し、バイオファブリケーションの潜在的応用を拡大する共同研究やパートナーシップを促進し、医療・製薬分野におけるこれらの技術の全体的な進歩と採用に寄与します。

医薬品検査は、バイオファブリケーション市場の成長を牽引する主要な用途です。高精度の人体組織を3Dプリントで作成できるため、医薬品の効果的な試験が可能になり、動物モデルへの依存度が低下し、医薬品の安全性評価が向上する可能性があります。バイオファブリケーション技術により、ヒトの生物学的性質を忠実に模倣した複雑な組織モデルの開発が可能になり、研究者は医薬品の有効性と毒性を評価するための信頼性の高いプラットフォームを手に入れることができます。この進歩は医薬品開発プロセスを大幅に強化し、バイオファブリケーションソリューションの需要拡大に貢献しています。

バイオファブリケーション市場レポートハイライト

技術別では、3Dバイオプリンティング分野が予測期間中に世界市場で大幅なCAGRを記録し、大幅な成長を遂げると予測されています。この成長は、精度と効率を高めた技術の進歩によるものです。

医薬品検査分野は、パイプライン医薬品の増加により、用途別では2023年に市場で最大の収益シェアを占めました。

2023年、北米は、病院数の増加、大手企業の存在により、世界のバイオファブリケーション市場を独占しました。

インドのバイオファブリケーション市場は、治験用パイプライン医薬品の増加により大幅な成長が予測されます。

世界の主要市場企業としては、Organovo Holdings, Inc.、Cellink、Allevi、Aspect Biosystems、Prellis Biologics、Tissue Regenix、NanoScribe、Pandorum International Inc.などが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のバイオファブリケーション市場の洞察

• 市場スナップショット
• バイオファブリケーション市場力学
  • 促進要因と機会
    • 再生医療の需要増加が市場規模を押し上げている
    • 組織工学と遺伝子治療への投資増加が市場の成長を牽引
  • 抑制要因と課題
    • バイオファブリケーション技術と材料の高コスト
• PESTEL分析
• バイオファブリケーション市場の動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界のバイオファブリケーション市場：技術別

• 主な調査結果
• イントロダクション
• 3Dバイオプリンティング
• 組織工学
• 生体材料の製造
• その他

第6章 世界のバイオファブリケーション市場：材料タイプ別

• 主な調査結果
• イントロダクション
• バイオインク
• 生物細胞
• 生体材料
• その他

第7章 世界のバイオファブリケーション市場：用途別

• 主な調査結果
• イントロダクション
• 再生医療
• 薬物検査
• 美容治療

第8章 世界のバイオファブリケーション市場：エンドユーザー別

• 主な調査結果
• イントロダクション
• 学術調査機関
• バイオテクノロジーおよび製薬企業
• 病院および専門クリニック

第9章 世界のバイオファブリケーション市場：地域別

• 主な調査結果
• イントロダクション
  • バイオファブリケーション市場評価：地域別、2020-2034年
• 北米
  • 北米：技術別、2020-2034年
  • 北米：材料タイプ別、2020-2034年
  • 北米：用途別、2020-2034年
  • 北米：エンドユーザー別、2020-2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：技術別、2020-2034年
  • 欧州：材料タイプ別、2020-2034年
  • 欧州：用途別、2020-2034年
  • 欧州：エンドユーザー別、2020-2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：技術別、2020-2034年
  • アジア太平洋地域：材料タイプ別、2020-2034年
  • アジア太平洋地域：用途別、2020-2034年
  • アジア太平洋地域：エンドユーザー別、2020-2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：技術別、2020-2034年
  • 中東・アフリカ：材料タイプ別、2020-2034年
  • 中東・アフリカ：用途別、2020-2034年
  • 中東・アフリカ：エンドユーザー別、2020-2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：技術別、2020-2034年
  • ラテンアメリカ：材料タイプ別、2020-2034年
  • ラテンアメリカ：用途別、2020-2034年
  • ラテンアメリカ：エンドユーザー別、2020-2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Organovo Holdings, Inc.
• Cellink
• Allevi
• Aspect Biosystems
• Prellis Biologics
• Tissue Regenix
• NanoScribe
• Pandorum International Inc.
• AstraZeneca
• Dr. Reddy's Laboratory
• BASF Corporation
• Sun Pharmaceuticals Industries Ltd.

List of Tables:

• Table 1 Global Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 2 Global Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 3 Global Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 4 Global Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 5 North America: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 6 North America: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 7 North America: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 8 North America: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 9 U.S.: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 10 U.S.: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 11 U.S.: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 12 U.S.: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 13 Canada: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 14 Canada: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 15 Canada: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 16 Canada: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 17 Europe: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 18 Europe: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 19 Europe: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 20 Europe: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 21 UK: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 22 UK: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 23 UK: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 24 UK: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 25 France: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 26 France: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 27 France: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 28 France: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 29 Germany: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 30 Germany: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 31 Germany: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 32 Germany: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 33 Italy: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 34 Italy: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 35 Italy: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 36 Italy: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 37 Spain: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 38 Spain: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 39 Spain: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 40 Spain: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 41 Netherlands: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 42 Netherlands: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 43 Netherlands: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 44 Netherlands: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 45 Russia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 46 Russia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 47 Russia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 48 Russia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 57 China: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 58 China: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 59 China: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 60 China: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 61 India: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 62 India: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 63 India: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 64 India: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 65 Malaysia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 66 Malaysia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 67 Malaysia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 68 Malaysia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 69 Japan: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 70 Japan: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 71 Japan: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 72 Japan: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 73 Indonesia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 74 Indonesia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 75 Indonesia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 76 Indonesia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 77 South Korea: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 78 South Korea: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 79 South Korea: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 80 South Korea: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 81 Australia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 82 Australia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 83 Australia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 84 Australia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 97 UAE: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 98 UAE: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 99 UAE: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 100 UAE: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 101 Israel: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 102 Israel: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 103 Israel: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 104 Israel: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 105 South Africa: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 106 South Africa: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 107 South Africa: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 108 South Africa: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 113 Latin America: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 114 Latin America: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 115 Latin America: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 116 Latin America: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 117 Mexico: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 118 Mexico: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 119 Mexico: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 120 Mexico: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 121 Brazil: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 122 Brazil: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 123 Brazil: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 124 Brazil: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 125 Argentina: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 126 Argentina: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 127 Argentina: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 128 Argentina: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Biofabrication Market, by Application, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• List of Figures:
• Figure 1. Global Biofabrication Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Technology
• Figure 7. Global Biofabrication Market, by Technology, 2024 & 2034 (USD Billion)
• Figure 8. Market by Material Type
• Figure 9. Global Biofabrication Market, by Material Type, 2024 & 2034 (USD Billion)
• Figure 10. Market by Application
• Figure 11. Global Biofabrication Market, by Application, 2024 & 2034 (USD Billion)
• Figure 12. Market by End User
• Figure 13. Global Biofabrication Market, by End User, 2024 & 2034 (USD Billion)

Figure 14. Global Biofabrication Market Assessment, By Geography, 2020-2034 (USD Billion)

• Figure 15. Strategic Analysis - Global Biofabrication Market

The biofabrication market size is expected to reach USD 31.69 billion by 2034, according to a new study by Polaris Market Research. The report "Biofabrication Market Size, Share, Trends, Industry Analysis Report: By Technology (3D Bioprinting and Tissue Engineering), Material Type, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The biofabrication market is growing primarily due to an increase in pipeline drugs worldwide as pharmaceutical companies and research institutions advance their drug development pipelines. With a rising number of drugs in various stages of development, the demand for sophisticated and accurate testing methods that can simulate human biological responses is expanding. Biofabrication technologies, which involve creating 3D-printed tissue models, offer a promising solution for this need. These technologies enable the development of complex tissue structures that closely replicate human organs and systems, providing a more reliable platform for evaluating the efficacy and safety of new drugs. It improves the accuracy of drug testing and reduces reliance on animal models, addressing ethical and regulatory concerns as the pharmaceutical industry continues to invest in novel therapies and treatments. The biofabrication market benefits from the increased need for innovative testing solutions. This growing demand underscores the critical role of biofabrication in accelerating drug development processes and enhancing the overall effectiveness of pharmaceutical research.

An increase in investments in research and development (R&D) from the private and public sectors is expected to boost the biofabrication market growth during the forecast period. Growing financial support is enabling advancements in biofabrication technologies, such as improved 3D bioprinting systems and novel biomaterials. This influx of investment fosters innovation, accelerates the development of new applications, and enhances the capabilities of biofabrication technologies. As funding continues to rise, research institutions and companies can explore more refined approaches to tissue engineering and regenerative medicine, further driving market growth. Increased investments support the development of advanced technologies and facilitate collaborations and partnerships that expand the potential applications of biofabrication, contributing to the overall advancement and adoption of these technologies in the medical and pharmaceutical fields.

Drug testing is a major application driving the biofabrication market growth. The ability to create highly accurate, 3D-printed human tissues allows for effective testing of pharmaceuticals, potentially reducing reliance on animal models and improving drug safety assessments. Biofabrication technologies enable the development of complex tissue models that closely mimic human biology, offering researchers a more reliable platform for evaluating drug efficacy and toxicity. This advancement significantly enhances the drug development process, contributing to the growing demand for biofabrication solutions.

Biofabrication Market Report Highlights

Based on technology, the 3D bioprinting segment is anticipated to experience substantial growth with a significant CAGR in the global market during the forecast period. This growth is attributed to advances in technology that have enhanced precision and efficiency.

The drug testing segment, by application, accounted for the largest revenue share of the market in 2023 due to an increase in pipeline drugs.

In 2023, North America dominated the global biofabrication market due to the increasing number of hospitals, the presence of major players.

The biofabrication market in India is projected for substantial growth due to the increasing number of pipeline drugs for trials.

A few global key market players are Organovo Holdings, Inc.; Cellink; Allevi; Aspect Biosystems; Prellis Biologics; Tissue Regenix; NanoScribe; and Pandorum International Inc.

Polaris Market Research has segmented the biofabrication market report on the basis of technology, material type, application, end user, and region:

By Technology Outlook (Revenue - USD billion, 2020-2034)

• 3D Bioprinting
• Tissue Engineering
• Biomaterial Fabrication
• Other
• By Material Type (Revenue - USD billion, 2020-2034)
• Bioinks
• Biological Cells
• Biomaterials
• Others
• By Application (Revenue - USD billion, 2020-2034)
• Regenerative Medicine
• Durg Testing
• Cosmetic Treatment
• By End User (Revenue - USD billion, 2020-2034)
• Academic and Research Institutes
• Biotechnology and Pharmaceutical Companies
• Hospitals and Specialty Clinics

By Regional Outlook (Revenue - USD billion, 2020-2034)

• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of APAC
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of MEA

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Biofabrication Market Insights

• 4.1. Biofabrication Market - Market Snapshot
• 4.2. Biofabrication Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increased in Demand for Regenerative Medicine is Driving the Market Size
    • 4.2.1.2. Increase in Investment in Tissue Engineering and Gene Therapy Are Driving the Market Growth
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Costs of Biofabrication Technology and Materials
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Biofabrication Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Biofabrication Market, by Technology

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Biofabrication Market, by Technology, 2020-2034 (USD Billion)
• 5.3. 3D Bioprinting
  • 5.3.1. Global Biofabrication Market, by 3D Bioprinting, by Region, 2020-2034 (USD Billion)
• 5.4. Tissue Engineering
  • 5.4.1. Global Biofabrication Market, by Tissue Engineering, by Region, 2020-2034 (USD Billion)
• 5.5. Biomaterial Fabrication
  • 5.5.1. Global Biofabrication Market, by Biomaterial Fabrication, by Region, 2020-2034 (USD Billion)
• 5.6. Others
  • 5.6.1. Global Biofabrication Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Biofabrication Market, by Material Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
• 6.3. Bioinks
  • 6.3.1. Global Biofabrication Market, by Bioinks, by Region, 2020-2034 (USD Billion)
• 6.4. Biological Cells
  • 6.4.1. Global Biofabrication Market, by Biological Cells, by Region, 2020-2034 (USD Billion)
• 6.5. Biomaterials
  • 6.5.1. Global Biofabrication Market, by Biomaterials, by Region, 2020-2034 (USD Billion)
• 6.6. Others
  • 6.6.1. Global Biofabrication Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Biofabrication Market, by Application

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Biofabrication Market, by Application, 2020-2034 (USD Billion)
• 7.3. Regenerative Medicine
  • 7.3.1. Global Biofabrication Market, by Regenerative Medicine, by Region, 2020-2034 (USD Billion)
• 7.4. Drug Testing
  • 7.4.1. Global Biofabrication Market, by Drug Testing, by Region, 2020-2034 (USD Billion)
• 7.5. Cosmetic Treatment
  • 7.5.1. Global Biofabrication Market, by Cosmetic Treatment, by Region, 2020-2034 (USD Billion)

8. Global Biofabrication Market, by End User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Biofabrication Market, by End User, 2020-2034 (USD Billion)
• 8.3. Academic and Research Institutes
  • 8.3.1. Global Biofabrication Market, by Academic and Research Institutes, by Region, 2020-2034 (USD Billion)
• 8.4. Biotechnology and Pharmaceutical Companies
  • 8.4.1. Global Biofabrication Market, by Biotechnology and Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
• 8.5. Hospitals and Specialty Clinics
  • 8.5.1. Global Biofabrication Market, by Hospitals and Specialty Clinics, by Region, 2020-2034 (USD Billion)

9. Global Biofabrication Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Biofabrication Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Biofabrication Market - North America
  • 9.3.1. North America: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
  • 9.3.2. North America: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
  • 9.3.3. North America: Biofabrication Market, by Application, 2020-2034 (USD Billion)
  • 9.3.4. North America: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.3.5. Biofabrication Market - U.S.
    • 9.3.5.1. U.S.: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.5.2. U.S.: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.3.5.3. U.S.: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5.4. U.S.: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.3.6. Biofabrication Market - Canada
    • 9.3.6.1. Canada: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• 9.4. Biofabrication Market - Europe
  • 9.4.1. Europe: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Biofabrication Market, by Application, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.4.5. Biofabrication Market - UK
    • 9.4.5.1. UK: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.4.6. Biofabrication Market - France
    • 9.4.6.1. France: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.4.7. Biofabrication Market - Germany
    • 9.4.7.1. Germany: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.4.8. Biofabrication Market - Italy
    • 9.4.8.1. Italy: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.4.9. Biofabrication Market - Spain
    • 9.4.9.1. Spain: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.4.10. Biofabrication Market - Netherlands
    • 9.4.10.1. Netherlands: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.4.11. Biofabrication Market - Russia
    • 9.4.11.1. Russia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.4.12. Biofabrication Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• 9.5. Biofabrication Market - Asia Pacific
  • 9.5.1. Asia Pacific: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Biofabrication Market, by Application, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.5.5. Biofabrication Market - China
    • 9.5.5.1. China: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.5.6. Biofabrication Market - India
    • 9.5.6.1. India: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.5.7. Biofabrication Market - Malaysia
    • 9.5.7.1. Malaysia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.5.8. Biofabrication Market - Japan
    • 9.5.8.1. Japan: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.5.9. Biofabrication Market - Indonesia
    • 9.5.9.1. Indonesia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.5.10. Biofabrication Market - South Korea
    • 9.5.10.1. South Korea: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.5.11. Biofabrication Market - Australia
    • 9.5.11.1. Australia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.5.12. Biofabrication Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• 9.6. Biofabrication Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Biofabrication Market, by Application, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.6.5. Biofabrication Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.6.6. Biofabrication Market - UAE
    • 9.6.6.1. UAE: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.6.7. Biofabrication Market - Israel
    • 9.6.7.1. Israel: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.6.8. Biofabrication Market - South Africa
    • 9.6.8.1. South Africa: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.6.9. Biofabrication Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Biofabrication Market, by End User, 2020-2034 (USD Billion)
• 9.7. Biofabrication Market - Latin America
  • 9.7.1. Latin America: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Biofabrication Market, by Application, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.7.5. Biofabrication Market - Mexico
    • 9.7.5.1. Mexico: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.7.6. Biofabrication Market - Brazil
    • 9.7.6.1. Brazil: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.7.7. Biofabrication Market - Argentina
    • 9.7.7.1. Argentina: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Biofabrication Market, by End User, 2020-2034 (USD Billion)
  • 9.7.8. Biofabrication Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Biofabrication Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Biofabrication Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Organovo Holdings, Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Cellink
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Allevi
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Aspect Biosystems
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Prellis Biologics
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Tissue Regenix
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. NanoScribe
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Pandorum International Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. AstraZeneca
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Dr. Reddy's Laboratory
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. BASF Corporation
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Sun Pharmaceuticals Industries Ltd.
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development